ReviewJournal of radiation research2024
Networking in biological and physical retrospective dosimetry in Europe and beyond.
Review in Journal of radiation research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Personalised Dosimetry in Nuclear Medicine: Bridging Physics, Biology and AI for Next Generation Radiopharmaceutical Therapy.Nuclear medicine and molecular imaging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Ionizing radiation is of huge benefit to society; however, the risks of radiation overexposure in occupational settings or due to accidents or other incidents are of growing concern, not least due to the potential implications for exposed individuals in terms of acute high dose (e.g. ARS) and/or longer term low dose health effects such as cancer or genetic effects. This manuscript considers the state of the art for biological and 'fortuitous' physical retrospective dose estimation either in blood or in materials being carried by suspected exposed individuals, respectively, in support of routine and emergency radiation incident response, and the potential future progress in this fascinating and active field. In recent years, international experts in this field have engaged in active collaboration and networking on support of these goals, and continued efforts in this area will ensure the global community remains ready to respond to radiation accidents and incidents. In addition, over and above improved dose and exposure characterization in the field of radiation emergency medicine, scientific developments in biological markers may contribute to potential contributions to individualized or stratified risk estimation in molecular epidemiology to assess long term, low dose radiation risk; in personalized medical dosimetry for better justification and optimization for use of radiation in such settings, and even perhaps for potential future situations involving radiation exposure, for example protection of individuals traveling to space.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.